Counterfeit Irminix® is being sold under our various trade names (OSR, NBMI, Emerimide) and tests have shown that it is not Irminix®.

Counterfeit Irminix® illegally being sold to the public

We are aware some companies are selling counterfeit Irminix. a substance that is promoted to work as our mercury chelation compound. In one case, a physician in Sweden purchased fake Irminix® online and tested it. He informed us that the product he bought online did not display the properties of our compound. Please reference the above picture. Irminix® dissolves in DMSO (clear solution) and the fake Irminix® internet counterfeit does not (as it contains an unknown white debris.)

Companies are selling counterfeit Irminix® with the warning “NOT FOR HUMAN CONSUMPTION” in big bold letters. This is good advice.

Our drug, Irminix® is pharmaceutically pure with virtually no contamination, made in the United States. It has specific physical properties and precise chemical bonds that studies have shown make it harmless to you.

What is the fake Irminix® made of?

So what is it the fake Irminix®, counterfeit drug made of? While we do not know specifically, we do know it is not the real thing. Since the counterfeit product would not dissolve in DMSO it may be a compound that has no resemblance at all chemically to Irminix®. On the other hand if at one time it was similar in structure to Irminix® it is possible the undissolved white substance is a combination of the heavy metals that Irminix® combines with irreversibly. Counterfeit Irminix® in your system may do real harm as ingestion of an unknown substance is a risk to your health.

Irminix® is a unique chelator

Irminix® is fat soluble when not combined with any of the following metals:

  • Mercury
  • Arsenic
  • Lead
  • Uranium
  • Gadolinium
  • Uranium
  • Thorium
  • Polonium

Don’t risk your health with fake chelators

Why risk your health ingesting unknown, fake, knock offs? The real Irminix® may be available in your country in compliance with various regulations through our Early Access Programme.